134 results about "Known Coronary Artery Disease" patented technology

The invention discloses a non-invasive central aortic blood pressure measuring method and device. The non-invasive central aortic blood pressure measuring method includes, according to a human artery network model based on viscous fluid mechanics, a method of calculating artery network model personalized parameters of a measured person through measured radial artery and brachial artery pulse wave signals and arm blood pressure values, a method of calculating an ascending aorta-radial artery transfer function and a method of calculating central arterial pressure waveforms through measured central arterial pressures. The non-invasive central aortic blood pressure continuous measuring device comprises a pulse wave signal processing and analysis unit and a radial artery and brachial artery pulse wave signal acquisition unit worn on a wrist. The method is different from an existing general transfer function method, the artery network model parameters of each person to be measured are measured and calculated and the artery network model parameters are numerical characteristics of the cardiovascular system states of the person to be measured with the calculated central arterial pressure waveforms, and the method and device has important meanings in prevention, curing and control of cardiovascular diseases, especially high-risk diseases, such as hypertensions and coronary heart diseases.

The invention provides mulberry leaf and tartary buckwheat fine dried noodles. The mulberry leaf and tartary buckwheat fine dried noodles are prepared from 55-70 parts by mass of tartary buckwheat flour, 15-30 parts by mass of wheat gluten, 5-15 parts by mass of high gluten wheat flour, 3-10 parts by mass of mulberry leaf powder, 0.5-1.5 parts by mass of edible salt, 0.3-0.7 part by mass of sodium carbonate, 0.1-0.3 part by mass of konjac gum, 0.1-0.3 part by mass of xanthan gum and 35-42 parts by mass of drinking water. A preparation method of the mulberry leaf and tartary buckwheat fine dried noodles comprises the processes of preparation of a noodle improver solution, dough kneading, ripening, tabletting, drying, packaging and the like. The products are unique in formula, have excellent taste, are rich in nutrients, have prominent health care functions and are suitable for all kinds of people to eat, especially patients with constipation, obesity, diabetes mellitus, hypertension and coronary heart diseases.

The invention discloses an application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy, which can be used for treating vascular nerve cephalalgia, cerebral thrombus, cerebrovascular angiosclerosis, coronary heart diseases, angina pectoris, hypertension, or asomnia, or common cold, or women's dysmenorrheal.

The invention discloses a method for preparing edible salt added with froggrass. Healthcare salt comprises commercial salt as a main ingredient and froggrass as a healthcare ingredient. The method comprises the following steps: drying commercial salt, adding a certain amount of froggrass into the salt, uniformly stirring, adding a certain amount of dextrin and seasonings into the salt, adding a proper amount of an anti-caking agent into the salt according to different needs, and performing subsequent operations of adding iodine, packaging and the like. The method is simple; the produced functional healthcare salt can be used for effectively overcoming the disadvantage of high possibility of diseases such as hypertension and coronary heart diseases due to excessive intake of sodium in traditional salt and bringing a healthcare effect of the froggrass into play to the hilt while ensuring a seasoning effect; the salt prepared by using the method is suitable for being used by various people.

The invention relates to an imaging method and a device for visualizing coronary heart disease, in particular cardiac infarction lesions, in which at least one image of the heart or heart region comprising at least the myocardium is recorded and reproduced using computed tomography part. The method is characterized in that, by windowing the measured data of the image or the data derived therefrom in the region of the myocardium, regions with insufficient blood supply and/or damage are segmented and displayed in the image in a distinctive manner. In particular, the method according to the invention and the associated device can be used to graphically display the extent of damage after a heart attack.

The invention provides a rosa davurica total flavone extract, its extracting method and its medical use, and relates to a traditional Chinese medicine extract in effective medical parts, an extracting method thereof and the medical use thereof. The invention comprises the following steps: drying and crushing traditional Chinese medicine rosa davurica and performing a heat backflow extraction by 65% to 75% of ethanol, putting an extraction solution into 30 to 60 meshes of polyamide column, washing to colorless and eluting with ethanol of the concentration of 65 to 75 %, collecting an eluent and recovering ethanol to obtain raw material medicines used for the research of new medicines of traditional Chinese medicine. According to the invention, the total flavone content in the extract detected by using an UV spectrophotometry method is more than 50%. The rosa davurica total flavone extract which is extracted and purified by the invention has the functions of treating coronary heart diseases, cardiac muscle ischemia, arrhythmia, hyperlipidemia and the like.

The present invention relates to a method for establishing a diagnosis if an individual has suffered from or a prognosis if an individual is at risk of suffering from a coronary heart event, which method comprises determining the concentration of sCD40L in a body fluid of the individual; determining the concentration of a proximal inflammatory marker, preferably PAPP-A or Lp-PLA2 comparing the values obtained with reference values; and establishing the diagnosis or the prognosis in respect to the cardiovascular event. The combination according to the invention can be used with further markers selected from further inflammatory markers, anti-inflammatory markers and/or neurohumoral markers.

A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I)

(wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of formula (I) is useful as a hypoglycemic agent, a hypolipidemic agent, a preventive and/or a remedy for diseases associating metabolic disorders (diabetes, obesity, syndrome X, hypercholesterolemia, hyperlipoproteinemia, etc.), hyperlipemia, atherosclerosis, hypertension, circulatory diseases, overeating, coronary heart diseases, etc., an HDL cholesterol-elevating agent, an LDL cholesterol and/or VLDL cholesterol-lowering agent and a drug for relief from risk factors of diseases or syndrome X.

The invention relates to bitter gourd and kudzuvine root yoghurt and a preparation method thereof. The preparation method comprises the following steps: mixing a milk product with bitter gourd juice, kudzuvine root liquid, a stabilizer and sucrose, and performing bacterial fermentation. The bitter gourd and kudzuvine root yoghurt contains various probiotics and active ingredients such as saponins and flavones, has the effects of clearing heat and toxic materials, dispelling the effects of alcohol, benefiting the stomach, protecting the liver and the like, and is capable of effectively reducing blood fat, blood pressure and blood sugar and assisting in treatment of coronary heart diseases and angina pectoris.

The invention relates to traditional Chinese medicine extract for treating stagnation of blood stasis as well as a preparation and a preparation method thereof. The traditional Chinese medicine extract is prepared by extracting 20 material medicines including red flowers, roots of common peony, ligusticum wallichii and the like. The traditional Chinese medicine extract has a very high curative effect for heart and cerebral vusculer diseases including cerebral infarction, coronary heart diseases and the like which are caused by stagnation of blood stasis, a small side effect and does not apply virulent animal medicines; a solid preparation prepared from the traditional Chinese medicine extract and auxiliary materials is preferably a pill or a tablet which has good stability, formability and effectiveness.

The invention discloses an LDCT image super-resolution enhancement method and device based on a residual convolutional neural network. According to the method, firstly, a network structure of an improved hybrid cascade task convolutional neural network (taking U-Net as an example) is designed, and then according to the designed network structure, a large number of LDCT low-resolution images and truth-value high-resolution images are provided for network training. The network training process is formed by performing feature extraction, error calculation and error back propagation on an improved hybrid cascade task U-Net, and back propagation is performed on an error value. The specified learning rate is 0.0001, the optimizer is ADAM, the learning rate adopts a stage decreasing strategy, and the loss between the super-resolution CT image and the true-value high-resolution image is continuously reduced. The method can be suitable for screening, detecting and analyzing three diseases (pulmonary nodules, chronic obstructive pulmonary diseases and coronary heart diseases) and the spine through one-time chest LDCT scanning in the medical field, and extra high-precision CT scanning does not need to be conducted on a certain local part of the chest with the higher spatial resolution requirement.

The invention discloses Chinese medicinal powder for treating an ischemic heart disease, which is prepared from six Chinese medicinal materials: American ginseng, root of red-rooted salvia, notoginseng root, dwarf lilyturf tuber, Chinese angelica and shizandra berry. In the Chinese medicinal powder has a formula of medicines, and is scientific and reasonable in compatibility; and the Chinese medicinal powder achieves the effects of nourishing heart, nourishing blood, promoting blood circulation and invigorating yang to consolidate constitution by nourishing heart and blood, invigorating yang to consolidate constitution and strengthening body resistance under the combined and synergistic action of the medicines, so the Chinese medicinal powder is particularly suitable for treating the ischemic heart disease and also has the obvious curative effect on other heart diseases, pulmonary heart diseases and emphysema. By the Chinese medicinal powder, the problem that the medicines for treating the ischemic heart disease have large side effect and the problem that coronary heart diseases and other heart and pulmonary diseases cannot be treated by one medicine but must be treated under the combined action of the medicines are solved; and various heart diseases caused by myocardial ischemia can be cured fundamentally to solve the problem that the ischemic heart disease is relapsed repeatedly after the treatment of the conventional medicine for treating the ischemic heart disease, and one medicine with multiple medicinal effects also relieves economic burdens for patients.

The invention relates to a pu-er tea ferment soft capsule which is capable of regulating yin-yang, sedating, and lowering blood pressure and is used for various vascular hypertensions and various complicating diseases of heart, brain and kidney caused by vascular hypertension. The medicament comprises pu-er tea extract, aweto, lumbricus, black-snakes, monascus purpureus, rhizoma dioscorea, wolfberry fruit, cassia seeds, tortoise shells, fleece-flower roots, roots of red rooted salvia, round cardamom, angelica dahurica, tangerine peels, spine date seeds, ginkgo biloba, safflower, hawthorn, and the like. The production method comprises the following steps: hydrolyzing pu-er tea to prepare pu-er tea extract by using the purification and zymohydrolysis method, mixing the sundried powders such as aweto, lumbricus, tortoise shells, fleece-flower roots, roots of red rooted salvia, and the like to make soft capsules. In the invention, effective components are largely reserved due to the adoption of the purification and zymohydrolysis method, the medical value of the soft capsule can be fully improved; the preparation can improve blood oxygen saturation, is suitable for the diseases such as vexation, chest distress, short breath, hypertension, hyperlipidemia, arteriosclerosis, arrhythmia, myocardial ischemia, angina pectoris, coronary heart diseases, strokes, and the like.

The present invention discloses soda sandwich biscuit capable of enhancing human body metabolic functions and a preparation method thereof. The soda sandwich biscuit comprises the following raw materials: wheat flour, palm oil, wafer sandwich, edible corn starch, white granulated sugar, shortening, cheese powder, edible salt, sodium hydrogen carbonate, yeast, edible essence and calcium hydrogen phosphate; wherein the cheese powder comprises the following raw materials: cheese, white granulated sugar, edible corn starch, capsanthin, silicon dioxide and edible essence; and wherein the wafer sandwich comprises the following raw materials: whole milk powder, sodium glutamate, citric acid, modified soybean phospholipids and turmeric. The produced biscuit is mellow in aroma, stable in color andluster, good in taste, and rich in linoleic acid and vitamin E, can effectively lower cholesterol, prevents hypertension and coronary heart diseases, can more effectively promote intestinal peristalsis, inhibits absorption of toxic substances, and enhances human body metabolic functions.

A method of treating patients with coronary heart failure (CHF) by the intermittent administration of Angiotensin Converting Enzyme (ACE) inhibitors and/or angiostatin II receptor agonists (ARBs) is disclosed. The ACE inhibitor is administered to the patient during a treatment period and the levels of hematopoietic stem cells (HSC) in the patient's blood is determined. Treatment with the ACE inhibitor is discontinued (during a recovery period) when the measured level of hematopoietic cells drops below a given point and is re-administered when levels rise above a given point. Alternating, treatment and recovery periods can be repeated a plurality of times. Levels of HSC may be determined based on ACE⁺ cell levels or by monitoring CD34 levels and the results used to determine optimum points for the administration of drugs which reduce HSC levels.

The invention discloses a traditional Chinese medicine (TCM) preparation for treating coronary heart diseases. The preparation is prepared from the following TCMs: fructus citri sarcodactylis, red beans, spina date seeds, grosvenor momordica fruit, semen pruni, honeysuckle, Chinese olive, heartleaf houttuynia herb, dried gingers, raisin tree seed, cape jasmine fruit, fructus amomi, mint, Japanese thistle root, coastal glehnia root, sterculia lychnophorae, Indian bread, citron, Chinese mosla herb, peach kernels, chrysanthemum, perilla seeds, kudzuvine root, black sesame, oranges, huckleberries, sophora japonica, radix onosmatis, cattail pollen, tall gastrodia tuber, fermented soybeans, heterophylly falsestarwort root, Chinese wolfberry root-bark, Chinese angelica, bamboo shavings, Sichuan lovage rhizome, salvia miltiorrhiza, common aucklandia root, great burdock achene and rhizoma drynariae. The TCM preparation has the beneficial effects that the TCM preparation has good treatment effects on coronary heart diseases, takes an effect quickly, is thorough in treatment, is simple in preparation method, is safe in clinical application, and does not have toxic or side effects.